Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking

Dayong Lee, Ryan G Vandrey, Damodara R. Mendu, Jeannie A. Murray, Allan J. Barnes, Marilyn A. Huestis

Research output: Contribution to journalArticle

Abstract

Oral fluid (OF) offers a simple, non-invasive, directly observable sample collection for clinical and forensic drug testing. Given that chronic cannabis smokers often engage in drug administration multiple times daily, evaluating OF cannabinoid pharmacokinetics during ad libitum smoking is important for practical development of analytical methods and informed interpretation of test results. Eleven cannabis smokers resided in a closed research unit for 51days, and underwent four, 5-day oral delta-9-tetrahydrocannabinol (THC) treatments. Each medication period was separated by 9days of ad libitum cannabis smoking from 12:00 to 23:00 h daily. Ten OF samples were collected from 9:00-22:00 h on each of the last ad libitum smoking days (Study Days 4, 18, 32, and 46). As the number of cannabis cigarettes smoked increased over the study days, OF THC, cannabinol (CBN), and 11-nor-9-carboxy-THC (THCCOOH) also increased with a significant effect of time since last smoking (Δtime; range, 0.0-17.4 h) and ≥88% detection rates; concentrations on Day 4 were significantly lower than those on Days 32 and 46 but not Day 18. Within 30min of smoking, median THC, CBN, and THCCOOH concentrations were 689 μg/L, 116 μg/L, and 147 ng/L, respectively, decreasing to 19.4 μg/L, 2.4 μg/L, and 87.6 ng/L after 10 h. Cannabidiol and 11-hydroxy-THC showed overall lower detection rates of 29 and 8.6%, respectively. Cannabinoid disposition in OF was highly influenced by Δtime and composition of smoked cannabis. Furthermore, cannabinoid OF concentrations increased over ad libitum smoking days, in parallel with increased cannabis self-administration, possibly reflecting development of increased cannabis tolerance.

Original languageEnglish (US)
Pages (from-to)494-501
Number of pages8
JournalDrug Testing and Analysis
Volume7
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

Marijuana Smoking
Cannabinoids
Cannabis
smoking
Dronabinol
Smoking
Fluids
fluid
Cannabinol
drug
Cannabidiol
Self Administration
Pharmacokinetics
Tobacco Products
Pharmaceutical Preparations
analytical method
tolerance
Research
Testing

Keywords

  • Cannabinoid
  • Cannabis
  • Delta-9-tetrahydrocannabinol
  • Oral fluid

ASJC Scopus subject areas

  • Analytical Chemistry
  • Environmental Chemistry
  • Pharmaceutical Science
  • Spectroscopy

Cite this

Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. / Lee, Dayong; Vandrey, Ryan G; Mendu, Damodara R.; Murray, Jeannie A.; Barnes, Allan J.; Huestis, Marilyn A.

In: Drug Testing and Analysis, Vol. 7, No. 6, 01.06.2015, p. 494-501.

Research output: Contribution to journalArticle

Lee, Dayong ; Vandrey, Ryan G ; Mendu, Damodara R. ; Murray, Jeannie A. ; Barnes, Allan J. ; Huestis, Marilyn A. / Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. In: Drug Testing and Analysis. 2015 ; Vol. 7, No. 6. pp. 494-501.
@article{8ab868326ba244ad97a8e750000ddb53,
title = "Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking",
abstract = "Oral fluid (OF) offers a simple, non-invasive, directly observable sample collection for clinical and forensic drug testing. Given that chronic cannabis smokers often engage in drug administration multiple times daily, evaluating OF cannabinoid pharmacokinetics during ad libitum smoking is important for practical development of analytical methods and informed interpretation of test results. Eleven cannabis smokers resided in a closed research unit for 51days, and underwent four, 5-day oral delta-9-tetrahydrocannabinol (THC) treatments. Each medication period was separated by 9days of ad libitum cannabis smoking from 12:00 to 23:00 h daily. Ten OF samples were collected from 9:00-22:00 h on each of the last ad libitum smoking days (Study Days 4, 18, 32, and 46). As the number of cannabis cigarettes smoked increased over the study days, OF THC, cannabinol (CBN), and 11-nor-9-carboxy-THC (THCCOOH) also increased with a significant effect of time since last smoking (Δtime; range, 0.0-17.4 h) and ≥88{\%} detection rates; concentrations on Day 4 were significantly lower than those on Days 32 and 46 but not Day 18. Within 30min of smoking, median THC, CBN, and THCCOOH concentrations were 689 μg/L, 116 μg/L, and 147 ng/L, respectively, decreasing to 19.4 μg/L, 2.4 μg/L, and 87.6 ng/L after 10 h. Cannabidiol and 11-hydroxy-THC showed overall lower detection rates of 29 and 8.6{\%}, respectively. Cannabinoid disposition in OF was highly influenced by Δtime and composition of smoked cannabis. Furthermore, cannabinoid OF concentrations increased over ad libitum smoking days, in parallel with increased cannabis self-administration, possibly reflecting development of increased cannabis tolerance.",
keywords = "Cannabinoid, Cannabis, Delta-9-tetrahydrocannabinol, Oral fluid",
author = "Dayong Lee and Vandrey, {Ryan G} and Mendu, {Damodara R.} and Murray, {Jeannie A.} and Barnes, {Allan J.} and Huestis, {Marilyn A.}",
year = "2015",
month = "6",
day = "1",
doi = "10.1002/dta.1718",
language = "English (US)",
volume = "7",
pages = "494--501",
journal = "Drug Testing and Analysis",
issn = "1942-7603",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking

AU - Lee, Dayong

AU - Vandrey, Ryan G

AU - Mendu, Damodara R.

AU - Murray, Jeannie A.

AU - Barnes, Allan J.

AU - Huestis, Marilyn A.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Oral fluid (OF) offers a simple, non-invasive, directly observable sample collection for clinical and forensic drug testing. Given that chronic cannabis smokers often engage in drug administration multiple times daily, evaluating OF cannabinoid pharmacokinetics during ad libitum smoking is important for practical development of analytical methods and informed interpretation of test results. Eleven cannabis smokers resided in a closed research unit for 51days, and underwent four, 5-day oral delta-9-tetrahydrocannabinol (THC) treatments. Each medication period was separated by 9days of ad libitum cannabis smoking from 12:00 to 23:00 h daily. Ten OF samples were collected from 9:00-22:00 h on each of the last ad libitum smoking days (Study Days 4, 18, 32, and 46). As the number of cannabis cigarettes smoked increased over the study days, OF THC, cannabinol (CBN), and 11-nor-9-carboxy-THC (THCCOOH) also increased with a significant effect of time since last smoking (Δtime; range, 0.0-17.4 h) and ≥88% detection rates; concentrations on Day 4 were significantly lower than those on Days 32 and 46 but not Day 18. Within 30min of smoking, median THC, CBN, and THCCOOH concentrations were 689 μg/L, 116 μg/L, and 147 ng/L, respectively, decreasing to 19.4 μg/L, 2.4 μg/L, and 87.6 ng/L after 10 h. Cannabidiol and 11-hydroxy-THC showed overall lower detection rates of 29 and 8.6%, respectively. Cannabinoid disposition in OF was highly influenced by Δtime and composition of smoked cannabis. Furthermore, cannabinoid OF concentrations increased over ad libitum smoking days, in parallel with increased cannabis self-administration, possibly reflecting development of increased cannabis tolerance.

AB - Oral fluid (OF) offers a simple, non-invasive, directly observable sample collection for clinical and forensic drug testing. Given that chronic cannabis smokers often engage in drug administration multiple times daily, evaluating OF cannabinoid pharmacokinetics during ad libitum smoking is important for practical development of analytical methods and informed interpretation of test results. Eleven cannabis smokers resided in a closed research unit for 51days, and underwent four, 5-day oral delta-9-tetrahydrocannabinol (THC) treatments. Each medication period was separated by 9days of ad libitum cannabis smoking from 12:00 to 23:00 h daily. Ten OF samples were collected from 9:00-22:00 h on each of the last ad libitum smoking days (Study Days 4, 18, 32, and 46). As the number of cannabis cigarettes smoked increased over the study days, OF THC, cannabinol (CBN), and 11-nor-9-carboxy-THC (THCCOOH) also increased with a significant effect of time since last smoking (Δtime; range, 0.0-17.4 h) and ≥88% detection rates; concentrations on Day 4 were significantly lower than those on Days 32 and 46 but not Day 18. Within 30min of smoking, median THC, CBN, and THCCOOH concentrations were 689 μg/L, 116 μg/L, and 147 ng/L, respectively, decreasing to 19.4 μg/L, 2.4 μg/L, and 87.6 ng/L after 10 h. Cannabidiol and 11-hydroxy-THC showed overall lower detection rates of 29 and 8.6%, respectively. Cannabinoid disposition in OF was highly influenced by Δtime and composition of smoked cannabis. Furthermore, cannabinoid OF concentrations increased over ad libitum smoking days, in parallel with increased cannabis self-administration, possibly reflecting development of increased cannabis tolerance.

KW - Cannabinoid

KW - Cannabis

KW - Delta-9-tetrahydrocannabinol

KW - Oral fluid

UR - http://www.scopus.com/inward/record.url?scp=84930274533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930274533&partnerID=8YFLogxK

U2 - 10.1002/dta.1718

DO - 10.1002/dta.1718

M3 - Article

VL - 7

SP - 494

EP - 501

JO - Drug Testing and Analysis

JF - Drug Testing and Analysis

SN - 1942-7603

IS - 6

ER -